MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis
LA JOLLA, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market […]
TSX News -
Titanium Transportation Group Reports Steady Q3 2024 Performance with 24% Increase in Volume in Logistics Segment
Consolidated third quarter revenue grew by 5.1% compared to the previous year, driven by strong performance in the Logistics segment […]
Serina Therapeutics Makes Grants to New Employees Under Inducement Plan
HUNTSVILLE, AL, Nov. 11, 2024 (GLOBE NEWSWIRE) — Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company advancing its […]
NEXGEL Announces $2,000,000 Registered Direct Offering
LANGHORNE, Pa., Nov. 11, 2024 (GLOBE NEWSWIRE) — NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of […]
Crown Point Announces Operating and Financial Results for the Three and Nine Months Ended September 30, 2024
CALGARY, Alberta, Nov. 11, 2024 (GLOBE NEWSWIRE) — TSX-V: CWV: Crown Point Energy Inc. (“Crown Point”, the “Company” or “we“) […]
23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future
Reduces workforce by roughly 40%; expects annualized cost savings of more than $35 million Discontinues development of therapeutics division and […]
TSX News -
Nexus Industrial REIT Announces Third Quarter 2024 Financial Results
Industrial weighting increasing as legacy assets are sold Net Operating Income grows 11.0% as recent investments yield returns TORONTO, Nov. […]
Volt Lithium Announces $5 Million Marketed Public Offering of Units and $1.1 Million Concurrent Private Placement of Units
CALGARY, Alberta, Nov. 11, 2024 (GLOBE NEWSWIRE) — Volt Lithium Corp. (TSXV: VLT) (“Volt” or the “Company“) is pleased to […]
Enstar Agrees ADC Agreement with James River
HAMILTON, Bermuda, Nov. 11, 2024 (GLOBE NEWSWIRE) — Enstar Group Limited (“Enstar”) (Nasdaq: ESGR) announced today that one of its […]
Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis
CANTON, Mass., Nov. 11, 2024 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on […]
